Ventricular Septal Rupture Following Myocardial Infarction 

  • Author: Shabir Bhimji, MD, PhD; Chief Editor: Brett C Sheridan, MD, FACS   more...
 
Updated: Dec 1, 2011
 

Background

Ventricular septal rupture (VSR) is a rare but lethal complication of myocardial infarction (MI). The event occurs 2-8 days after an infarction and often precipitates cardiogenic shock.[1] The differential diagnosis of postinfarction cardiogenic shock should exclude free ventricular wall rupture and rupture of the papillary muscles. To avoid the high morbidity and mortality associated with this disorder, patients should undergo emergent surgery.[2, 3, 4, 5] Concomitant coronary artery bypass may be required. Developments in myocardial protection and improved prosthetic materials have contributed greatly to successful management of VSR.[6] Long-term survival can be achieved in patients who undergo prompt surgery.

For information, news, and CME activities on heart failure, visit Medscape’s Heart Failure Resource Center.

Next

History of the Procedure

Latham first described this condition at autopsy in 1847, but he did not make the association between acquired VSR and coronary artery disease (CAD). Brunn made the first antemortem diagnosis of acquired VSR in 1923, and, in 1934, Sager established the clinical association between MI and VSR.

No surgical treatment was available until 1957, when Cooley et al performed the first successful surgical repair of VSR in a patient 9 weeks after the diagnosis. Unfortunately, the patient died 6 weeks later.

Principal treatment of postinfarction VSR during the early 1960s consisted of aggressive medical management, although it was well known that survival was rare after medical treatment alone. Surgical therapy was generally reserved for patients who survived at least 6 weeks, primarily to allow for scarring of the edges of the defect. A secure and long-lasting closure was thought to occur if the edges of the VSR were strong enough to hold the sutures.

By the late 1960s, early surgical repair was proposed for patients whose conditions were deteriorating despite medical therapy. The timely introduction of better prosthetic material significantly contributed to the successful surgical repair of acute VSR.[6]

More recently, improved surgical techniques (eg, infarctectomy), myocardial protection, and better perioperative mechanical and pharmacological support have helped to lower mortality rates. In addition, the development of surgical techniques to repair perforations in different areas of the ventricular septum have led to improved results in the management of patients with postinfarction VSR.

Previous
Next

Epidemiology

Frequency

Rupture of the interventricular septum is an uncommon complication of MI. Although autopsy studies reveal an 11% incidence rate of myocardial free wall rupture after MI, septal wall perforation is much less common, occurring at rate of approximately 1-2%.

VSR occurs in a zone of necrotic myocardial tissue, and it usually occurs within the first 10-14 days. Clinical studies report an average time of 2.6 days from infarction to septal rupture. However, recent data suggest that the initial treatment of MI with thrombolytics may affect both the time between infarction and septal rupture and outcome. The early use of thrombolytic agents may lead to reopening of the occluded vessels, thus reducing the incidence of VSR.

The age range of patients who sustain a postinfarction VSR is wide, from 44-81 years. Men are affected more commonly than women, although septal rupture is more common in women than would be predicted based on the prevalence of CAD alone.

Previous
Next

Pathophysiology

The blood supply to the septum originates from branches of the left anterior descending coronary artery, the posterior descending branch of the right coronary artery, or the circumflex artery when it is dominant. An infarction associated with a VSR is usually transmural and extensive. Approximately 60% of septal ruptures occur with infarction of the anterior wall; 40% occur with infarction of the posterior or inferior wall. Posterior VSR may be accompanied by mitral valve insufficiency secondary to papillary muscle infarction or dysfunction. At autopsy, patients with VSR usually show complete coronary artery occlusion with little or no collateral flow. The lack of collateral flow may be secondary to associated arterial disease, anatomic anomalies, or myocardial edema. Sometimes, multiple septal perforations occur. These may occur simultaneously or within several days of each other.

Ventricular aneurysms are commonly associated with postinfarction VSR and contribute significantly to the hemodynamic compromise in these patients. The reported incidence rate of ventricular aneurysms ranges from 35-68%, whereas the incidence of ventricular aneurysms alone following MI without VSR is considerably less (12.4%).

Previous
Next

Presentation

Natural history

The natural history of postinfarction VSR is greatly influenced by hypertension, anticoagulation therapy, advanced age, and, possibly, thrombolytic therapy. The natural course in patients with postinfarction VSR is well documented and short. Most patients die within the first week; almost 90% die within the first year. Reports indicate that fewer than 7% of patients are alive after 1 year. This grim prognosis results from an acute volume overload exacted on both ventricles in a heart already compromised by a large MI and occasionally by extensive CAD in sites other than that already infarcted. In addition, superimposed ischemic mitral valve regurgitation, a ventricular aneurysm, or a combination of these conditions may be present, which further compromises heart function. The depressed left ventricular function commonly leads to impaired peripheral organ perfusion and death in most patients.

A few sporadic reports indicate that some patients with medically treated postinfarction VSR live for several years. Although many medical advances have been made in the nonsurgical treatment of these patients, including intra-aortic balloon counterpulsation (IABCP), these methods have not replaced the need for surgery.

Differential diagnosis

An important diagnostic test for differentiating VSR from mitral valve insufficiency is catheterization of the right heart with a Swan-Ganz catheter. In the presence of a VSR, oxygen concentration between the right atrium and the pulmonary artery is stepped up. In addition, a pulmonary capillary wedge pressure tracing is beneficial for differentiating acute mitral regurgitation from VSR. Left- and right-sided pressure measurements help estimate the degree of biventricular failure and are useful in monitoring the response to perioperative therapy. Although right-sided failure is more common in patients with postinfarction VSR, left-sided failure and refractory pulmonary edema are more prominent in patients with ruptured papillary muscle. However, a third of patients with postinfarction VSR also have some mitral regurgitation secondary to left ventricular dysfunction. Only rarely is VSR also associated with ruptured papillary muscle.

History and physical examination

Upon auscultation, a loud systolic murmur is heard, usually within the first week after an acute MI. This is the most consistent physical finding of postinfarction VSR. Prior to the development of the murmur, the patient may have been stable after the acute MI. Coincident with the onset of the murmur, the patient's clinical course undergoes a sudden deterioration, with the development of congestive heart failure and, often, cardiogenic shock. The typical harsh systolic murmur is audible over a large area, including the left sternal border and apical area. The murmur sometimes radiates to the left axilla, thereby mimicking mitral regurgitation. A thrill is palpable in approximately 50% of patients.

Almost 50% of patients have recurrent chest pain. The differential diagnosis includes VSR and mitral insufficiency secondary to papillary muscle rupture, papillary muscle dysfunction, or left ventricular dilatation.

Summary of features of postinfarction VSR

  • Occurrence is typically 3-8 days after an MI.
  • The sites of rupture are the anterior septum (60%) and the posterior septum (40%).
  • The most consistent finding is a murmur.
  • In the differential diagnosis, exclude mitral regurgitation from papillary muscle rupture.
  • Diagnosis is confirmed with the aid of echocardiography and the presence of a left-to-right shunt.
  • Catheterization results help determine the extent of CAD.
  • Of patients treated without surgery, 90% die.
  • Surgery must be emergent, even if the patient is stable.[3]
  • All VSRs are closed with a patch and associated coronary artery bypass grafting.
  • The surgical mortality rate for anterior defects is 10-15% and for posterior defects is 30-35%.
Previous
Next

Indications

In view of the grim prognosis of medically treated patients, simply the diagnosis of postinfarction ventricular septal rupture (VSR) is an indication for operation. The previous controversy surrounding the timing of surgical intervention is no longer an issue, and most surgeons agree that early surgery should be performed in order to incur the lowest risk of mortality and morbidity. The success of the surgery depends on the prompt medical stabilization of the patient and the prevention of cardiogenic shock.

The relative safety of repair 2-3 weeks or more after perforation is apparent from the previous data. Because the edges of the defect have become firmer and fibrotic, repair is more secure and easily accomplished. A successful clinical outcome is related to the adequacy of closure of the VSR; therefore, if possible, search for multiple defects preoperatively and certainly at the time of surgery. Only when the patient is hemodynamically stable should repair be initially delayed, but there must be high degree of certainty that the patient is hemodynamically stable. These patients can suddenly deteriorate and die.

The criteria for a delay in surgery include adequate cardiac output, no evidence of cardiogenic shock, an absence of signs and symptoms of congestive heart failure or minimal use of pressor agents to control initial symptoms, an absence of fluid retention, and good renal function. The natural history of the disease is such that few patients present with these signs and symptoms.

In most patients, postinfarction VSR rapidly leads to a worsening of the hemodynamic state, with cardiogenic shock, marked and intractable symptoms of congestive heart failure, and fluid retention. Immediate surgery is usually indicated.[7] The high surgical risk of early repair is accepted because of the even higher risk of death without surgery under such circumstances.

Occasionally, a delay in diagnosis and referral occurs. These patients are usually critically ill, and the prognosis is very grim; thus, allowing the natural history of the disease to take its course is prudent.[7]

Previous
Next

Contraindications

Generally, most patients who experience a postinfarction ventricular septal rupture (VSR) need emergent surgery. However, because of either delayed diagnosis or referral, an occasional patient may be in a state of multiorgan failure and may not be a candidate for surgery. The chances of such a patient surviving an operation are minimal; in these circumstances, supportive medical therapy may be adequate. Patients who are comatose and in cardiogenic shock have a particularly poor prognosis after surgery, and surgery is best avoided in such circumstances.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Shabir Bhimji, MD, PhD  Locum Cardiothoracic and Vascular Surgeon, Saudi Arabia and Middle East Hospitals

Shabir Bhimji, MD, PhD is a member of the following medical societies: American Cancer Society, American College of Chest Physicians, American Lung Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey C Milliken, MD  Chief, Division of Cardiothoracic Surgery, University of California at Irvine Medical Center; Clinical Professor, Department of Surgery, University of California, Irvine, School of Medicine

Jeffrey C Milliken, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for Thoracic Surgery, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Heart Association, American Society for Artificial Internal Organs, California Medical Association, International Society for Heart and Lung Transplantation, Phi Beta Kappa, Society of Thoracic Surgeons, Southwest Oncology Group, and Western Surgical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Shreekanth V Karwande, MBBS  Chair, Professor, Department of Surgery, Division of Cardiothoracic Surgery, University of Utah School of Medicine and Medical Center

Shreekanth V Karwande, MBBS is a member of the following medical societies: American Association for Thoracic Surgery, American College of Chest Physicians, American College of Surgeons, American Heart Association, Society of Critical Care Medicine, Society of Thoracic Surgeons, and Western Thoracic Surgical Association

Disclosure: Nothing to disclose.

Rajalaxmi McKenna, MD, FACP  Southwest Medical Consultants, SC, Department of Medicine, Good Samaritan Hospital, Advocate Health Systems

Rajalaxmi McKenna, MD, FACP is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology, and International Society on Thrombosis and Haemostasis

Disclosure: Nothing to disclose.

Chief Editor

Brett C Sheridan, MD, FACS  Associate Professor of Surgery, University of North Carolina at Chapel Hill School of Medicine

Disclosure: Nothing to disclose.

References
  1. Koh AS, Loh YJ, Lim YP, Le Tan J. Ventricular septal rupture following acute myocardial infarction. Acta Cardiol. Apr 2011;66(2):225-30. [Medline].

  2. David TE. Operative management of postinfarction ventricular septal defect. Semin Thorac Cardiovasc Surg. Oct 1995;7(4):208-13. [Medline].

  3. Gaudiani VA, Miller DG, Stinson EB, et al. Postinfarction ventricular septal defect: an argument for early operation. Surgery. Jan 1981;89(1):48-55. [Medline].

  4. Roberts JD, So DY, Lambert AS, Ruel M. Successful surgical repair of ventricular double rupture. Can J Cardiol. Nov 2011;27(6):868.e5-7. [Medline].

  5. Kuthe SA, Mohite PN, Sarangi S, Mathews S, Thingnam SK, Reddy S. Repair of postinfarct ventricular septal defect and total myocardial revascularization in a case of dextrocardia with situs inversus. Gen Thorac Cardiovasc Surg. Jan 2011;59(1):42-4. [Medline].

  6. Daggett WM, Buckley MJ, Akins CW, et al. Improved results of surgical management of postinfarction ventricular septal rupture. Ann Surg. Sep 1982;196(3):269-77. [Medline].

  7. Heitmiller R, Jacobs ML, Daggett WM. Surgical management of postinfarction ventricular septal rupture. Ann Thorac Surg. Jun 1986;41(6):683-91. [Medline].

  8. Deja MA, Szostek J, Widenka K, et al. Post infarction ventricular septal defect - can we do better?. Eur J Cardiothorac Surg. Aug 2000;18(2):194-201. [Medline].

  9. Cummings RG, Califf R, Jones RN, et al. Correlates of survival in patients with postinfarction ventricular septal defect. Ann Thorac Surg. Jun 1989;47(6):824-30. [Medline].

  10. Muehrcke DD, Daggett WM. Current surgical approach to acute ventricular septal rupture. Adv Card Surg. 1995;6:69-90. [Medline].

  11. Cooley DA. Repair of the difficult ventriculotomy. Ann Thorac Surg. Jan 1990;49(1):150-1. [Medline].

  12. Daggett WM. Surgical technique for early repair of posterior ventricular septal rupture. J Thorac Cardiovasc Surg. Aug 1982;84(2):306-12. [Medline].

  13. Ellis CJ, Parkinson GF, Jaffe WM, et al. Good long-term outcome following surgical repair of post-infarction ventricular septal defect. Aust N Z J Med. Aug 1995;25(4):330-6. [Medline].

  14. Jacobs ML, Daggett WM. Postinfarction ventricular septal rupture. In: Grillo HC, Austen WG, Wilkins EW Jr, Mathisen DJ, Vlahakes GJ, eds. Current Therapy in Cardiothoracic Surgery. 2nd ed. Toronto, Ont: BC Decker; 1989:. 435-7.

  15. Komeda M, Fremes SE, David TE. Surgical repair of postinfarction ventricular septal defect. Circulation. Nov 1990;82(5 Suppl):IV243-7. [Medline].

  16. Landzberg MJ, Lock JE. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin Thorac Cardiovasc Surg. Apr 1998;10(2):128-32. [Medline].

  17. Piwnica A. Update in surgical treatment of acute post infarction VSDs and MIs. Eur J Cardiothorac Surg. 1995;9(3):117-9. [Medline].

  18. von Segesser LK, Siebenmann R, Schneider K, et al. Postinfarction ventricular septal defect--surgical strategies and results. Thorac Cardiovasc Surg. Apr 1989;37(2):72-5. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.